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BACKGROUND: Mechanical ventilation is commonly used in Intensive Care Units for 
supplying supplementary oxygen to critically ill people. However, mechanical ventilation itself 
often damages the recipient’s lungs. This damage is termed ventilator-induced lung injury 
(VILI) and is associated with poor clinical outcomes. There are currently no effective 
pharmacological treatments for VILI prevention or treatment in routine clinical use. 
METHOD: This study investigated 2 drugs aimed at therapeutic targets in mechanically 
ventilated lungs using an isolated perfused rat lung preparation (Hugo Sachs 
Elektronik/Harvard Apparatus IPL-2). Respiratory parameters were recorded using 
ADInstruments PowerLab and LabChart software. A hyperbaric model of VILI was 
developed. Lungs were maintained at normal tidal volume for 10 min using positive pressure 
ventilation (between +3 to +15 cmH2O), and then hyperinflated by increasing the peak end-
inspiratory pressure to +30 cmH2O for a period of 1 h. After this, a 90 min measurement 
period was undertaken at normal negative breathing pressures (-2 to -12 cmH2O).  In 
treatment experiments (n=7), the drug was added to the recirculating perfusate 7 min prior to 
lung hyperinflation. Findings were compared to determine whether drug treatment reduced 
the severity of VILI.  
RESULTS: The VILI model optimisation was successful, with hyperinflation resulting in an 
increase in tidal volume from 2.0 to 4.8 mL and a corresponding steady rise in lung weight  
by 16% associated with visible oedema in the lower lung lobes. The abnormal increased 
lung weight was sustained over the following 90 min normal ventilation period as well.  
In the drug treatment group the weight gain and tissue oedema were significantly less 
severe in the hyperinflation injury period and normal ventilation periods after drug treatment.  
CONCLUSION: It was found possible to pharmacologically attenuate the severity of 
experimental VILI using biochemical methods.  
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